|Combination antiretroviral therapy and the risk of myocardial infarction|
Data Collection on Adverse Events of Anti-HIV Drugs (DAD) Study Group
New England Journal of Medicine 349 (21), 1993-2003, 2003
|Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D: A: D study: a multi-cohort collaboration|
The Lancet 371 (9622), 1417-1426, 2008
|Causes of death among human immunodeficiency virus (HIV)-infected adults in the era of potent antiretroviral therapy: emerging role of hepatitis and cancers, persistent role of …|
C Lewden, D Salmon, P Morlat, S Bévilacqua, E Jougla, F Bonnet, ...
International journal of epidemiology 34 (1), 121-130, 2005
|Liver disease as a major cause of death among HIV infected patients: role of hepatitis C and B viruses and alcohol|
D Salmon-Ceron, C Lewden, P Morlat, S Bévilacqua, E Jougla, F Bonnet, ...
Journal of hepatology 42 (6), 799-805, 2005
|Changes in causes of death among adults infected by HIV between 2000 and 2005: The “Mortalite 2000 and 2005” surveys (ANRS EN19 and Mortavic)|
C Lewden, T May, E Rosenthal, C Burty, F Bonnet, D Costagliola, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 48 (5), 590-598, 2008
|Malignancy‐related causes of death in human immunodeficiency virus–infected patients in the era of highly active antiretroviral therapy|
F Bonnet, C Lewden, T May, L Heripret, E Jougla, S Bevilacqua, ...
Cancer 101 (2), 317-324, 2004
|HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies|
Data Collection on Adverse Events of Anti-HIV Drugs (D: A: D) Study Group
AIDS (London, England) 22 (16), 2143, 2008
|Causes of death among HIV-infected patients in France in 2010 (national survey): trends since 2000|
P Morlat, C Roussillon, S Henard, D Salmon, F Bonnet, P Cacoub, ...
Aids 28 (8), 1181-1191, 2014
|Phase II trial of CHOP plus rituximab in patients with HIV-associated non-Hodgkin's lymphoma|
F Boué, J Gabarre, C Gisselbrecht, J Reynes, A Cheret, F Bonnet, ...
Journal of Clinical Oncology 24 (25), 4123-4128, 2006
|CD4 cell count and HIV DNA level are independent predictors of disease progression after primary HIV type 1 infection in untreated patients|
C Goujard, M Bonarek, L Meyer, F Bonnet, ML Chaix, C Deveau, M Sinet, ...
Clinical Infectious Diseases 42 (5), 709-715, 2006
|Changes in cancer mortality among HIV-infected patients: the Mortalite 2005 Survey|
F Bonnet, C Burty, C Lewden, D Costagliola, T May, V Bouteloup, ...
Clinical infectious diseases 48 (5), 633-639, 2009
|Management of noninfectious mixed cryoglobulinemia vasculitis: data from 242 cases included in the CryoVas survey|
B Terrier, E Krastinova, I Marie, D Launay, A Lacraz, P Belenotti, ...
Blood, The Journal of the American Society of Hematology 119 (25), 5996-6004, 2012
|An internationally generalizable risk index for mortality after one year of antiretroviral therapy|
JP Tate, AC Justice, MD Hughes, F Bonnet, P Reiss, A Mocroft, ...
AIDS (London, England) 27 (4), 563, 2013
|Evaluation of cardiovascular risk factors in HIV-1 infected patients using carotid intima-media thickness measurement|
P Mercié, R Thiébaut, V Lavignolle, JL Pellegrin, MC Yvorra-Vives, ...
Annals of medicine 34 (1), 55-63, 2002
|Tobacco addiction and HIV infection: toward the implementation of cessation programs. ANRS CO3 Aquitaine Cohort|
A Bénard, F Bonnet, JF Tessier, H Fossoux, M Dupon, P Mercié, ...
AIDS patient care and STDs 21 (7), 458-468, 2007
|Cognitive disorders in HIV-infected patients: are they HIV-related?|
F Bonnet, H Amieva, F Marquant, C Bernard, M Bruyand, FA Dauchy, ...
Aids 27 (3), 391-400, 2013
|The spectrum of type I cryoglobulinemia vasculitis: new insights based on 64 cases|
B Terrier, A Karras, JE Kahn, G Le Guenno, I Marie, L Benarous, A Lacraz, ...
Medicine 92 (2), 61, 2013
|Causes of death among HIV‐infected patients in the era of highly active antiretroviral therapy, Bordeaux, France, 1998–1999|
F Bonnet, P Morlat, G Chene, P Mercie, D Neau, I Chossat, M Decoin, ...
HIV medicine 3 (3), 195-199, 2002
|Role of uncontrolled HIV RNA level and immunodeficiency in the occurrence of malignancy in HIV-infected patients during the combination antiretroviral therapy era: Agence …|
M Bruyand, R Thiébaut, S Lawson-Ayayi, P Joly, AJ Sasco, P Mercié, ...
Clinical infectious diseases 49 (7), 1109-1116, 2009
|Emerging role of hepatocellular carcinoma among liver-related causes of deaths in HIV-infected patients: The French national Mortalite 2005 study|
D Salmon-Ceron, E Rosenthal, C Lewden, V Bouteloup, T May, C Burty, ...
Journal of hepatology 50 (4), 736-745, 2009